Structure-activity relationships of rifamycin derivatives
- PMID: 5371662
Structure-activity relationships of rifamycin derivatives
Similar articles
-
Chemotherapeutic activity of new derivatives of rifamycin.Antimicrob Agents Chemother (Bethesda). 1966;6:359-64. Antimicrob Agents Chemother (Bethesda). 1966. PMID: 5985258 No abstract available.
-
[Rifampicin: a new antitubercular agent].Wiad Lek. 1972 Feb 1;25(3):251-4. Wiad Lek. 1972. PMID: 5010254 Polish. No abstract available.
-
New derivatives of rifamycin SV.Antimicrob Agents Chemother (Bethesda). 1965;5:765-9. Antimicrob Agents Chemother (Bethesda). 1965. PMID: 4956802 No abstract available.
-
Recent trends in rifamycin research.Bioessays. 1994 Mar;16(3):211-6. doi: 10.1002/bies.950160313. Bioessays. 1994. PMID: 7513153 Review.
-
Rifampin and pyrazinamide for latent tuberculosis infection: clinical trials and general practice.Clin Infect Dis. 2004 Aug 15;39(4):566-8. doi: 10.1086/422728. Epub 2004 Jul 30. Clin Infect Dis. 2004. PMID: 15356823 Review. No abstract available.
Cited by
-
Transcription leads to pervasive replisome instability in bacteria.Elife. 2017 Jan 16;6:e19848. doi: 10.7554/eLife.19848. Elife. 2017. PMID: 28092263 Free PMC article.
-
Rifampin in the treatment of pulmonary tuberculosis.Calif Med. 1972 Dec;117(6):18-21. Calif Med. 1972. PMID: 4635395 Free PMC article.
-
Clinical uses and control of rifampicin and clindamycin.J Clin Pathol. 1971 Jul;24(5):410-8. doi: 10.1136/jcp.24.5.410. J Clin Pathol. 1971. PMID: 4999067 Free PMC article. No abstract available.